Skip to content

Panax ginseng

Also called Asian ginseng, Korean ginseng, Chinese ginseng, red ginseng, white ginseng. Herbal root (adaptogen in traditional use).

Panax ginseng: ginsenoside Rg1, a major ginsenoside; the root is a mixtureOOHOOHOOOHHOOHHOOHHOHOOH
Panax ginseng: ginsenoside Rg1, a major ginsenoside; the root is a mixture.C42H72O14Structure: PubChem CID 441923, National Center for Biotechnology Information
Evidence last reviewed Added to the site 29 studies citedEditorial review: NootropicsWork Editorial TeamEducational, not medical advice

Bottom line

Panax ginseng (Asian or Korean ginseng) has small, inconsistent placebo-controlled evidence for memory and fatigue, mostly from short trials [1][2][3]. Trials and meta-analyses found no consistent benefit for exercise performance [4][5]. Side effects in trials are usually mild, but it may alter how some medicines are processed [6][7].

  • A 2010 Cochrane review found a lack of convincing evidence that Panax ginseng enhances cognition in healthy participants, and a 2024 meta-analysis of 15 trials, which mixed healthy people with clinical groups, found only a small memory effect [2][1].
  • In a 2023 meta-analysis of 19 randomized trials, ginseng did not significantly reduce fatigue overall, though it reduced general, non-disease fatigue with a small effect [3].
  • A meta-analysis of eight placebo-controlled trials found no improvement in physical performance (SMD = -0.01) [4].
  • In 12 healthy participants, 28 days of Panax ginseng lowered blood levels of a probe drug for the liver enzyme CYP3A, suggesting enzyme induction [7].
  • Health Canada's monograph tells product labels to advise asking a health care practitioner before use with some medicines, including antidepressants and blood thinners, or in pregnancy, breastfeeding or diabetes [8].

New to Panax ginseng? Start with What is Panax ginseng? A plain-English guide.

Evidence by outcome

OutcomeGradeBasisModifiersRationale
MemoryC LimitedC: small crossover RCTs in healthy adults with mixed results; the only pooled memory estimate mixes healthy and clinical populationsShort-term onlySingle research groupWhy C grade for Memory: explainedApproved of the Memory grade
Mental fatigueC LimitedC (conservative reading of mixed evidence, citation-rules 9): positive pooled results exist only in subgroups or small meta-analyses; the largest meta-analysis found no overall effectSubjective outcome onlyWhy C grade for Mental fatigue: explainedApproved of the Mental fatigue grade
CalmnessC Limited, no effect foundC: one small RCT with a restricted positive finding, one RCT finding no effect on well-beingSubjective outcome onlyShort-term onlySingle research groupWhy C grade for Calmness: explainedApproved of the Calmness grade
Endurance performanceN No benefit shown, no effect foundN: adequate human RCTs and two meta-analyses found no meaningful effectWhy N grade for Endurance performance: explainedApproved of the Endurance performance grade

Grades describe evidence for each outcome, not a recommendation. Open a grade for its rationale and dated grade history. How we grade

Most ginseng trials are small: NCCIH notes that most clinical trials have had fewer than 200 participants and lasted less than 3 months [9]. A 2023 umbrella review of 19 meta-analyses rated 14 of them as critically low quality [15]. Our evidence grading method explains what each grade requires. Ginseng's grades sit alongside other compounds in the evidence matrix and on the memory, energy, physical performance and mood and stress hubs.

Does Panax ginseng improve memory?

A 2024 meta-analysis of 15 randomized controlled trials (671 participants) found a small improvement in memory compared with control (SMD = 0.19, 95% CI 0.02-0.36), larger at high doses (SMD = 0.33) [1]. The same analysis found no effect on overall cognition, attention or executive function, and it combined healthy people with groups who had cognitive impairment, schizophrenia or Alzheimer's disease, so it does not isolate healthy adults [1].

The Cochrane review, which searched the literature on February 24, 2009, identified nine randomized, double-blind, placebo-controlled trials, eight of them in healthy participants [2]. It could not pool the data because the trials differed in outcomes, duration and dose, and concluded there is a lack of convincing evidence of a cognitive-enhancing effect in healthy participants [2].

The healthy-adult trials are short crossover studies, in which each person takes every treatment in turn, using one branded extract, G115 [16][17][18]. In 20 healthy young adults given 200, 400 or 600 mg of G115 or placebo, 400 mg improved a "Quality of Memory" score at all test times [16]. The same trial found that 200 and 600 mg slowed a "Speed of Attention" score at later test times, and self-rated alertness fell 6 hours after the two lowest doses [16]. A review by the same research group described this pattern as memory benefits that can come with "costs" on attention tasks [19]. That trial tested G115, an extract supplied by Pharmaton SA [16].

NCCIH summarizes the cognitive research as suggesting possible benefits in middle-aged adults but not in young adults, and notes that memory benefits appeared to depend on adding ginkgo [9].

Does Panax ginseng reduce fatigue or mental tiredness?

Evidence is mixed. In a 2023 meta-analysis of 19 randomized trials, ginseng did not significantly reduce fatigue severity overall compared with controls (SMD = -0.36, 95% CI -0.82 to 0.11) [3]. In subgroups, it reduced general, non-disease-specific fatigue (SMD = -0.48, 95% CI -0.71 to -0.25), and the authors noted that effect sizes were small [3]. The review pooled single-herb ginseng with multi-herb ginseng formulas, and its authors credited the benefit mainly to the formulas [3]. NCCIH says Asian ginseng alone may have a small benefit for general fatigue not related to specific diseases [9].

An earlier meta-analysis found reduced fatigue in a fixed-effect analysis of four placebo-controlled trials (SMD = 0.34, 95% CI 0.16 to 0.52) [4]. Its authors still judged the clinical evidence insufficient, because only a few small trials had been published [4]. A systematic review of 10 studies of Asian and American ginseng in people with fatigue, mostly with chronic illness, found modest evidence of efficacy [12]; results may not apply to healthy adults.

In healthy young adults, the evidence is two small crossover trials of G115 during demanding mental tasks [18][20]. In 30 participants given single doses, 200 mg improved a subtraction task and reduced self-rated mental fatigue at most test points compared with placebo [18]. In 27 participants, 200 mg improved mental arithmetic and lessened the rise in mental fatigue during sustained tasks [20].

Does Panax ginseng improve exercise performance?

In controlled trials, no consistent benefit was detected [4][5]. No effect was seen on physical performance in a meta-analysis of eight placebo-controlled randomized trials (SMD = -0.01, 95% CI -0.29 to 0.27) [4]. A 2022 meta-analysis of 14 studies in athletes and active participants found no effect on most outcomes; the only significant effect observed was on vertical jump at high doses in the short term [5]. The effect size reported for that vertical-jump finding is implausibly large for its measure, so we do not rely on it [5].

Individual trials agree. In a placebo-controlled trial of 28 healthy young adults, 200 mg a day for 3 weeks did not change peak oxygen uptake, exercise time, workload or lactate [21]. In 31 healthy men who completed an 8-week trial of 200 or 400 mg a day of G115, ginseng did not change oxygen use, heart rate, lactate or perceived exertion compared with placebo [22]. A systematic review of 14 red ginseng trials found no improvement in aerobic capacity, although its authors noted the studies were few and the results mixed [23].

Does Panax ginseng affect mood or calmness?

The evidence is thin. In a crossover trial of 30 healthy young adults, 400 mg of G115 improved self-rated calmness, but only at 2.5 and 4 hours on the first day, and also improved mental arithmetic [17]. In the same trial, 200 mg slowed a fall in mood but slowed responses on the arithmetic task, and eight days of use added no benefit over a single dose [17]. A separate randomized, placebo-controlled trial gave 83 healthy young adults 200 or 400 mg of G115 or placebo for 8 weeks and found no effect on positive affect, negative affect or total mood disturbance [24].

What the evidence does not show

Long-term evidence is thin. A 2003 review of the human research found a lack of adequately controlled studies of repeated, long-term use [19], and the healthy-adult trials on this page lasted from a single dose to 8 weeks [16][17][22].

Research in older adults with mild cognitive impairment, Alzheimer's disease or dementia (a clinical population) is separate. A 2026 meta-analysis of 9 studies (617 patients) found slightly higher scores on a cognitive screening test (MMSE mean difference 0.38), but the improvement did not reach the threshold for clinical significance [25]. Results may not apply to healthy adults.

Doses used in studies

Ranges researchers used, not dosing advice. Bars share one scale. Read our disclaimer.

Acute memory, attention and mental fatigue trials (G115)single doses of 200-600 mg200 to 600 mg
Mood and calmness trials (G115)200 or 400 mg a day for 8 days to 8 weeks400 mg
Exercise performance trials200-400 mg a day for 3-8 weeks200 to 400 mg
Trials in a safety review by authors affiliated with a ginseng manufacturerG115 100-400 mg; Korean red ginseng powder 0.9-6 g100 to 400 mg

Timing and form

EMA describes ginseng root medicines as dried or steamed root, powders, liquid, soft or dry extracts, and herbal teas [10]. The acute cognitive trials tested people at set times after a single dose, from 1 hour up to 6 hours later [16][18]. A 2017 review reports that blood absorption of compound K, a ginsenoside metabolite, starts 4 hours after a dose of ginseng powder [11].

What it is

Panax ginseng is a plant native to Korea, northeastern China and far-eastern Siberia, and the root is the part most often used for health purposes [9]. White ginseng is the dried root, while red ginseng is root that has been steamed and then dried [10]. It has been used as a calming agent in traditional Chinese medicine and as an adaptogen, a herb thought to help the body resist stress [9].

"Ginseng" on a label does not always mean this plant, because other herbs are sold under the same name [11]. American ginseng (Panax quinquefolius) is a separate Panax species grown in the United States and Canada [11], and reviews describe Asian and American ginseng as two different types [12]. Siberian ginseng, also called eleuthero (Eleutherococcus senticosus), is not a Panax species at all and contains eleutherosides rather than ginsenosides [11][13]. Findings on this page are for Panax ginseng unless stated otherwise. Some reviews cited here also included American ginseng or multi-herb formulas, and we say so where they do.

How it works (mechanism, not effect): the compounds thought to matter most are ginsenosides, a family of about thirty triterpene glycosides [9][11]. Most ginsenosides are converted by gut bacteria into intestinal metabolites [14], and in the liver they are metabolized by the enzyme CYP3A4 [11]. Only 0.2%–1.2% of ginsenosides leave the body intact in urine [11].

Safety and interactions

Safety flag. In trials, adverse events with ginseng alone occurred at rates similar to placebo; headache, sleep problems and digestive upset were most common [6]. Nervous system effects such as insomnia have been reported above 2.5 g a day [11]. EMA advises against use in pregnancy, breastfeeding and under 18 years because of a lack of adequate data [10]. Single doses lowered blood glucose levels in healthy young adults [18]. LiverTox scores ginseng E (by itself, unlikely to cause clinically apparent liver injury) but notes possible herb-drug interactions that can lead to liver injury; ginsenoside content of products varies widely [36].

Who sources say should be careful.

  • Pregnancy and breastfeeding: the European Medicines Agency advises against ginseng root medicines in pregnancy or breastfeeding because of a lack of adequate data [10]. In rodent embryo cultures, the ginsenosides Rb1, Rg1 and Re had embryotoxic effects [11]. A systematic review found one cohort study with no adverse effects in pregnancy, but still advised caution in pregnancy, especially the first trimester, and in breastfeeding, where no human safety studies exist [32].
  • Children and adolescents: EMA advises against use under 18 years because of a lack of adequate data [10], and NCCIH notes that some experts advise against use in infants and children [9].
  • People with diabetes or taking antidepressants, blood thinners or digoxin: Health Canada requires a label statement to ask a practitioner before use [8].
  • People with autoimmune conditions or on immune-stimulating therapies: a review advises caution [11], and NCCIH notes ginseng may worsen autoimmune disorders [9].
  • People allergic to the plant [10].

A systematic review of adverse effects concluded that the rate of adverse events with ginseng alone is similar to placebo, with headache, sleep problems and digestive upset the most common [6]. A systematic review of 65 randomized trials recorded 135 minor adverse events and no serious ones across the 40 trials that reported them [27]. A review of 44 trials (3,092 participants) found no significant difference from placebo in adverse events; its authors are affiliated with the research institute of the Korea Ginseng Corporation, a ginseng manufacturer [26].

NCCIH reports that short-term use by mouth, up to 6 months, in "recommended amounts" appears to be safe for most people, and that insomnia is the most common side effect [9]. It lists uncommon reports of severe rash, liver damage and severe allergic reactions, and notes that Asian ginseng may worsen autoimmune disorders and interfere with blood clotting [9]. The European Medicines Agency lists stomach discomfort, nausea, vomiting, diarrhea, constipation, skin reactions such as hives or itching, and insomnia, and says their frequency is not known [10].

Higher intakes bring more reports. A 2017 review notes insomnia and other nervous system effects in people taking more than 2.5 g a day, and a "ginseng abuse syndrome" of nervous system overactivity, skin eruptions and morning diarrhea has been described with high intakes of up to 15 g a day [11]. The same review reports vaginal bleeding and breast pain in some users, attributed to an estrogen-like effect [11]. Products that combine ginseng with other ingredients have been linked to serious adverse events and even fatalities, though other ingredients may have been responsible [6].

Ginseng may lower blood sugar. In healthy young adults, single doses of 200 or 400 mg lowered blood glucose levels [18], and NCCIH notes the same possibility [9]. In a crossover trial in young healthy volunteers, a drink with 800 mg of Panax ginseng did not significantly change ECG or blood pressure readings compared with placebo [28].

LiverTox, an NIH reference on liver injury, scores ginseng E: by itself, an unlikely cause of clinically apparent liver injury [36]. It notes that ginseng may cause herb-drug interactions that can lead to liver injury, and that commercial products vary widely in ginsenoside content, some containing none [36]. The entry covers Asian and American ginseng together.

Interactions sources report

A review of human interaction studies found they have been conflicting and have largely yielded negative results or only weak interactions [14]. In 12 healthy participants, 28 days of Panax ginseng (500 mg twice daily) reduced exposure to midazolam (geometric mean ratio for AUC 0.66), which suggests ginseng induced the liver enzyme CYP3A [7]; the review above describes this induction as weak [14]. Its authors advised close monitoring for people taking CYP3A-processed medicines with a narrow therapeutic range [7].

In an open-label randomized crossover study of 12 healthy men, 7 days of ginseng did not change warfarin levels or its effect on blood clotting (INR) [29]. In a randomized open-label study of 25 patients newly diagnosed with ischemic stroke (a clinical population), adding Panax ginseng did not change INR compared with warfarin alone [30]. A review of pharmacokinetic interactions concluded that interactions appear rare but still suggested close monitoring with warfarin and with narrow-range CYP3A or P-gp medicines [14]. American ginseng, a different species, did reduce warfarin's effect in a randomized trial of 20 healthy people [31]. A 2017 review advises that people on warfarin, other anticoagulants or antiplatelet drugs avoid ginseng supplements because of bleeding risk [11].

Other reports involve antidepressants. A systematic review records possible interactions with warfarin, phenelzine and alcohol [6], and psychiatric patients taking ginseng with phenelzine or other monoamine oxidase inhibitors have reported headaches, tremor and manic episodes [11]. A review also urges caution with digoxin and corticosteroids [11]. LiverTox describes liver injury that developed 1 to 3 months after people taking imatinib or raltegravir started ginseng; they had tolerated those medicines before and tolerated them again without ginseng [36]. The European Medicines Agency notes that no interactions had been described in the literature at the time of its assessment [10].

If you take any of these medicines, talk to your doctor or pharmacist before combining them with Panax ginseng.

FAQ

Is Korean ginseng the same as American ginseng?

No. Korean (Asian) ginseng is Panax ginseng, while American ginseng is Panax quinquefolius, a different species [11]. Reviews describe them as two types of ginseng [12], and an interaction trial found American ginseng reduced warfarin's effect [31], so findings for one do not automatically apply to the other.

Is Siberian ginseng a type of Panax ginseng?

No. Siberian ginseng (eleuthero, Eleutherococcus senticosus) is not a Panax species and contains eleutherosides rather than ginsenosides [11]. It has its own, separate research [13].

Does ginseng give you energy?

Evidence is mixed. A 2023 meta-analysis of 19 trials found no significant overall reduction in fatigue, but a small reduction in general, non-disease fatigue [3]. Small trials in healthy young adults found less self-rated mental fatigue during demanding tasks after 200 mg of one extract [18][20].

Is Panax ginseng safe to take with medicines?

Human interaction studies have given conflicting results, mostly negative or weak [14]. One study found ginseng sped up the processing of a CYP3A test drug [7], and two warfarin studies found no change [29][30], but one review still suggests close monitoring with warfarin [14] and another advises people on anticoagulants or antiplatelet drugs to avoid ginseng supplements because of bleeding risk [11]. LiverTox describes liver injury when ginseng was added to imatinib or raltegravir [36]. Health Canada requires labels to advise asking a practitioner before use with antidepressants, blood thinners or digoxin [8]. Talk to your doctor or pharmacist about your own medicines.

References

  1. Zeng M, Zhang K, Yang J, et al. Effects of Ginseng on Cognitive Function: A Systematic Review and Meta-Analysis. Phytother Res. 2024.PMID 39474788DOI 10.1002/ptr.8359Tier 1, meta-analysis
  2. Geng J, Dong J, Ni H, et al. Ginseng for cognition. Cochrane Database Syst Rev. 2010.PMID 21154383DOI 10.1002/14651858.CD007769.pub2Tier 1, meta-analysis
  3. Li X, Yang M, Zhang YL, et al. Ginseng and Ginseng Herbal Formulas for Symptomatic Management of Fatigue: A Systematic Review and Meta-Analysis. J Integr Complement Med. 2023.PMID 36730693DOI 10.1089/jicm.2022.0532Tier 1, meta-analysis
  4. Bach HV, Kim J, Myung SK, et al. Efficacy of Ginseng Supplements on Fatigue and Physical Performance: a Meta-analysis. J Korean Med Sci. 2016.PMID 27822924DOI 10.3346/jkms.2016.31.12.1879Tier 1, meta-analysis
  5. Khan N, Sharma S, Dahiya I, et al. Dose-response and temporal ergogenic effects of ginseng supplementation in athletes and active participants: A systematic review and meta-analysis. J Sports Sci. 2022.PMID 36604650DOI 10.1080/02640414.2022.2162753Tier 1, meta-analysis
  6. Coon JT, Ernst E. Panax ginseng: a systematic review of adverse effects and drug interactions. Drug Saf. 2002.PMID 12020172DOI 10.2165/00002018-200225050-00003Tier 1, systematic review
  7. Malati CY, Robertson SM, Hunt JD, et al. Influence of Panax ginseng on cytochrome P450 (CYP)3A and P-glycoprotein (P-gp) activity in healthy participants. J Clin Pharmacol. 2012.PMID 21646440DOI 10.1177/0091270011407194Tier 1, controlled trial
  8. Health Canada, Natural and Non-prescription Health Products Directorate. Panax ginseng (NHPID monograph). Updated June 27, 2025.SourceTier 1
  9. National Center for Complementary and Integrative Health (NIH). Asian Ginseng: Usefulness and Safety. 2025-02.SourceTier 2
  10. European Medicines Agency (HMPC). Ginseng radix (herbal medicine summary and EU herbal monograph documents). 2026-03-12 (public summary); monograph revision 1 published 2024-07-12.SourceTier 1
  11. Mancuso C, Santangelo R. Panax ginseng and Panax quinquefolius: From pharmacology to toxicology. Food Chem Toxicol. 2017.PMID 28698154DOI 10.1016/j.fct.2017.07.019Tier 1, narrative review
  12. Arring NM, Millstine D, Marks LA, et al. Ginseng as a Treatment for Fatigue: A Systematic Review. J Altern Complement Med. 2018.PMID 29624410DOI 10.1089/acm.2017.0361Tier 1, systematic review
  13. Eschbach LF, Webster MJ, Boyd JC, et al. The effect of siberian ginseng (Eleutherococcus senticosus) on substrate utilization and performance. Int J Sport Nutr Exerc Metab. 2000.PMID 11099371DOI 10.1123/ijsnem.10.4.444Tier 1, RCT
  14. Ramanathan MR, Penzak SR. Pharmacokinetic Drug Interactions with Panax ginseng. Eur J Drug Metab Pharmacokinet. 2017.PMID 27864798DOI 10.1007/s13318-016-0387-5Tier 1, narrative review
  15. Li Z, Wang Y, Xu Q, et al. Ginseng and health outcomes: an umbrella review. Front Pharmacol. 2023.PMID 37465522DOI 10.3389/fphar.2023.1069268Tier 1, systematic review
  16. Kennedy DO, Scholey AB, Wesnes KA. Dose dependent changes in cognitive performance and mood following acute administration of Ginseng to healthy young volunteers. Nutr Neurosci. 2001.PMID 11842896DOI 10.1080/1028415x.2001.11747370Tier 1, controlled trial
  17. Reay JL, Scholey AB, Kennedy DO. Panax ginseng (G115) improves aspects of working memory performance and subjective ratings of calmness in healthy young adults. Hum Psychopharmacol. 2010.PMID 20737519DOI 10.1002/hup.1138Tier 1, RCT
  18. Reay JL, Kennedy DO, Scholey AB. Single doses of Panax ginseng (G115) reduce blood glucose levels and improve cognitive performance during sustained mental activity. J Psychopharmacol. 2005.PMID 15982990DOI 10.1177/0269881105053286Tier 1, RCT
  19. Kennedy DO, Scholey AB. Ginseng: potential for the enhancement of cognitive performance and mood. Pharmacol Biochem Behav. 2003.PMID 12895687DOI 10.1016/s0091-3057(03)00126-6Tier 1, narrative review
  20. Reay JL, Kennedy DO, Scholey AB. Effects of Panax ginseng, consumed with and without glucose, on blood glucose levels and cognitive performance during sustained 'mentally demanding' tasks. J Psychopharmacol. 2006.PMID 16401645DOI 10.1177/0269881106061516Tier 1, RCT
  21. Allen JD, McLung J, Nelson AG, et al. Ginseng supplementation does not enhance healthy young adults' peak aerobic exercise performance. J Am Coll Nutr. 1998.PMID 9791844DOI 10.1080/07315724.1998.10718795Tier 1, RCT
  22. Engels HJ, Wirth JC. No ergogenic effects of ginseng (Panax ginseng C.A. Meyer) during graded maximal aerobic exercise. J Am Diet Assoc. 1997.PMID 9336557DOI 10.1016/S0002-8223(97)00271-XTier 1, RCT
  23. Lee NH, Jung HC, Lee S. Red Ginseng as an Ergogenic Aid: A Systematic Review of Clinical Trials. J Exerc Nutrition Biochem. 2016.PMID 28150477DOI 10.20463/jenb.2016.0034Tier 1, narrative review
  24. Cardinal BJ, Engels HJ. Ginseng does not enhance psychological well-being in healthy, young adults: results of a double-blind, placebo-controlled, randomized clinical trial. J Am Diet Assoc. 2001.PMID 11424544DOI 10.1016/S0002-8223(01)00165-1Tier 1, RCT
  25. Chen N, Yu L, Hua Q, et al. Ginseng for Cognitive Function in Elderly Adults with Mild Cognitive Impairment, Alzheimer's Disease, or Dementia: A Systematic Review and Meta-Analysis. Curr Neuropharmacol. 2026.PMID 41863264DOI 10.2174/011570159X415818251222083130Tier 1, meta-analysis
  26. Kim YS, Woo JY, Han CK, et al. Safety Analysis of Panax Ginseng in Randomized Clinical Trials: A Systematic Review. Medicines (Basel). 2015.PMID 28930204DOI 10.3390/medicines2020106Tier 1, narrative review
  27. Shergis JL, Zhang AL, Zhou W, et al. Panax ginseng in randomised controlled trials: a systematic review. Phytother Res. 2013.PMID 22969004DOI 10.1002/ptr.4832Tier 1, systematic review
  28. Shah SA, Occiano A, Nguyen TA, et al. Electrocardiographic and blood pressure effects of energy drinks and Panax ginseng in healthy volunteers: A randomized clinical trial. Int J Cardiol. 2016.PMID 27240158DOI 10.1016/j.ijcard.2016.05.007Tier 1, RCT
  29. Jiang X, Williams KM, Liauw WS, et al. Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol. 2004.PMID 15089812DOI 10.1111/j.1365-2125.2003.02051.xTier 1, RCT
  30. Lee SH, Ahn YM, Ahn SY, et al. Interaction between warfarin and Panax ginseng in ischemic stroke patients. J Altern Complement Med. 2008.PMID 18637764DOI 10.1089/acm.2007.0799Tier 1, RCT
  31. Yuan CS, Wei G, Dey L, et al. Brief communication: American ginseng reduces warfarin's effect in healthy patients: a randomized, controlled Trial. Ann Intern Med. 2004.PMID 15238367DOI 10.7326/0003-4819-141-1-200407060-00011Tier 1, RCT
  32. Seely D, Dugoua JJ, Perri D, et al. Safety and efficacy of panax ginseng during pregnancy and lactation. Can J Clin Pharmacol. 2008.PMID 18204104Tier 1, systematic review
  33. U.S. Food and Drug Administration. Dietary Supplements. Updated October 1, 2024.SourceTier 1
  34. Medicines and Healthcare products Regulatory Agency. Herbal medicines granted a traditional herbal registration (THR), list dated October 29, 2026. Updated November 2, 2026.SourceTier 1
  35. Australian Government, Department of Health, Disability and Ageing (Federal Register of Legislation). Therapeutic Goods (Permissible Ingredients) Determination (No. 3) 2026 (F2026L01382), volumes 1 and 5. Updated October 13, 2026.SourceTier 1
  36. LiverTox (NIH, NCBI Bookshelf). LiverTox: Ginseng (NBK548200). Updated March 14, 2018.SourceTier 2
Reviewed by NootropicsWork Editorial Team, editorial team. Checklist logged . Next review due . Report an error